25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ARDX (Ardelyx) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ardelyx together

I guess you are interested in Ardelyx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Ardelyx’s Financial Insights
  • 📈 Technical Analysis (TA) – Ardelyx’s Price Targets

I'm going to help you getting a better view of Ardelyx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ardelyx Inc

I send you an email if I find something interesting about Ardelyx Inc.

1. Quick Overview

1.1. Quick analysis of Ardelyx (30 sec.)










1.2. What can you expect buying and holding a share of Ardelyx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.61
Expected worth in 1 year
$0.59
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-0.5%

For what price can you sell your share?

Current Price per Share
$4.48
Expected price per share
$3.49 - $6.53
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ardelyx (5 min.)




Live pricePrice per Share (EOD)
$4.48
Intrinsic Value Per Share
$-4.88 - $-4.69
Total Value Per Share
$-4.27 - $-4.09

2.2. Growth of Ardelyx (5 min.)




Is Ardelyx growing?

Current yearPrevious yearGrowGrow %
How rich?$145.6m$158m-$1.9m-1.2%

How much money is Ardelyx making?

Current yearPrevious yearGrowGrow %
Making money-$13.4m-$16.4m$3m22.4%
Net Profit Margin-18.7%-51.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Ardelyx (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#287 / 874

Most Revenue
#95 / 874

Most Profit
#575 / 874

Most Efficient
#431 / 874
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ardelyx?

Welcome investor! Ardelyx's management wants to use your money to grow the business. In return you get a share of Ardelyx.

First you should know what it really means to hold a share of Ardelyx. And how you can make/lose money.

Speculation

The Price per Share of Ardelyx is $4.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ardelyx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ardelyx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.61. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ardelyx.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.17-3.8%-0.06-1.3%-0.07-1.5%-0.06-1.4%-0.09-2.1%-0.09-2.0%
Usd Book Value Change Per Share-0.10-2.3%-0.01-0.1%0.030.6%0.030.6%0.00-0.1%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.030.6%0.010.2%0.010.1%0.000.1%
Usd Total Gains Per Share-0.10-2.3%-0.01-0.1%0.051.2%0.040.8%0.000.0%0.010.3%
Usd Price Per Share4.91-6.07-5.24-4.56-4.55-6.36-
Price to Earnings Ratio-7.14--119.22--1.09--40.04--27.78--19.58-
Price-to-Total Gains Ratio-48.53--63.13-127.10-27.32-13.51--19.09-
Price to Book Ratio8.06-9.42-8.04-7.74-8.23-11.33-
Price-to-Total Gains Ratio-48.53--63.13-127.10-27.32-13.51--19.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.48
Number of shares223
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (223 shares)-1.220.18
Gains per Year (223 shares)-4.860.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5-155-4-9
20-10-2010-8-8
30-15-2515-12-7
40-19-3019-16-6
50-24-3524-21-5
60-29-4029-25-4
70-34-4534-29-3
80-39-5039-33-2
90-44-5544-37-1
100-49-6048-410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%5.035.00.012.5%7.042.01.014.0%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%8.012.00.040.0%14.026.00.035.0%17.030.03.034.0%
Dividend per Share0.00.04.00.0%1.00.011.08.3%2.00.018.010.0%2.00.038.05.0%2.00.048.04.0%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%9.011.00.045.0%15.025.00.037.5%18.029.03.036.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ardelyx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.101-0.005-95%0.027-480%0.028-456%-0.005-95%0.009-1204%
Book Value Per Share--0.6090.649-6%0.660-8%0.556+9%0.518+18%0.551+11%
Current Ratio--4.1234.236-3%4.397-6%3.658+13%4.194-2%7.702-46%
Debt To Asset Ratio--0.6450.597+8%0.439+47%0.515+25%0.475+36%0.342+89%
Debt To Equity Ratio--1.8161.498+21%0.820+121%1.132+60%0.973+87%0.654+178%
Dividend Per Share----0%0.027-100%0.009-100%0.005-100%0.003-100%
Enterprise Value--1124176089.2801435198319.025-22%1297049879.440-13%1105746170.310+2%1131674624.218-1%1605258336.005-30%
Eps---0.172-0.056-67%-0.069-60%-0.065-62%-0.093-46%-0.089-48%
Ev To Ebitda Ratio---7.73215.035-151%-6.238-19%2.587-399%-2.778-64%-8.026+4%
Ev To Sales Ratio--3.7924.148-9%8.719-57%9.224-59%71.989-95%791.658-100%
Free Cash Flow Per Share---0.162-0.051-68%-0.085-48%-0.076-53%-0.095-41%-0.090-45%
Free Cash Flow To Equity Per Share---0.1560.005-2958%0.070-322%0.039-503%-0.005-97%0.010-1589%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.694----------
Intrinsic Value_10Y_min---4.877----------
Intrinsic Value_1Y_max---0.328----------
Intrinsic Value_1Y_min---0.384----------
Intrinsic Value_3Y_max---1.094----------
Intrinsic Value_3Y_min---1.251----------
Intrinsic Value_5Y_max---1.991----------
Intrinsic Value_5Y_min---2.218----------
Market Cap1071862435.840-10%1174742089.2801458356319.025-19%1254294379.440-6%1092030086.977+8%1089824774.218+8%1521252261.005-23%
Net Profit Margin---0.555-0.187-66%-0.516-7%-1.682+203%-11.411+1955%-80.127+14333%
Operating Margin---0.600-0.155-74%-0.438-27%-1.577+163%-11.011+1735%-76.808+12699%
Operating Ratio--1.4591.138+28%1.488-2%2.607-44%12.139-88%97.440-99%
Pb Ratio7.358-10%8.0649.420-14%8.040+0%7.736+4%8.228-2%11.330-29%
Pe Ratio-6.513+9%-7.138-119.224+1570%-1.093-85%-40.037+461%-27.783+289%-19.578+174%
Price Per Share4.480-10%4.9106.070-19%5.243-6%4.556+8%4.550+8%6.356-23%
Price To Free Cash Flow Ratio-6.910+9%-7.573283.870-103%-19.860+162%88.143-109%48.526-116%14.355-153%
Price To Total Gains Ratio-44.277+9%-48.527-63.129+30%127.102-138%27.317-278%13.510-459%-19.090-61%
Quick Ratio--5.8495.887-1%6.476-10%4.933+19%5.755+2%9.995-41%
Return On Assets---0.100-0.035-65%-0.058-42%-0.067-33%-0.112+12%-0.116+15%
Return On Equity---0.282-0.093-67%-0.113-60%-0.148-47%-0.218-23%-0.193-32%
Total Gains Per Share---0.101-0.005-95%0.054-289%0.037-371%0.001-12553%0.012-952%
Usd Book Value--145676000.000156063000.000-7%158007250.000-8%133327833.333+9%124017750.000+17%131833325.000+11%
Usd Book Value Change Per Share---0.101-0.005-95%0.027-480%0.028-456%-0.005-95%0.009-1204%
Usd Book Value Per Share--0.6090.649-6%0.660-8%0.556+9%0.518+18%0.551+11%
Usd Dividend Per Share----0%0.027-100%0.009-100%0.005-100%0.003-100%
Usd Enterprise Value--1124176089.2801435198319.025-22%1297049879.440-13%1105746170.310+2%1131674624.218-1%1605258336.005-30%
Usd Eps---0.172-0.056-67%-0.069-60%-0.065-62%-0.093-46%-0.089-48%
Usd Free Cash Flow---38782000.000-12182500.000-69%-20281000.000-48%-18134583.333-53%-22822050.000-41%-21494525.000-45%
Usd Free Cash Flow Per Share---0.162-0.051-68%-0.085-48%-0.076-53%-0.095-41%-0.090-45%
Usd Free Cash Flow To Equity Per Share---0.1560.005-2958%0.070-322%0.039-503%-0.005-97%0.010-1589%
Usd Market Cap1071862435.840-10%1174742089.2801458356319.025-19%1254294379.440-6%1092030086.977+8%1089824774.218+8%1521252261.005-23%
Usd Price Per Share4.480-10%4.9106.070-19%5.243-6%4.556+8%4.550+8%6.356-23%
Usd Profit---41144000.000-13440500.000-67%-16453000.000-60%-15456916.667-62%-22182950.000-46%-21377825.000-48%
Usd Revenue--74114000.00090426500.000-18%39777500.000+86%48656250.000+52%30039900.000+147%17807400.000+316%
Usd Total Gains Per Share---0.101-0.005-95%0.054-289%0.037-371%0.001-12553%0.012-952%
 EOD+3 -5MRQTTM+4 -33YOY+4 -353Y+15 -245Y+14 -2510Y+12 -27

3.3 Fundamental Score

Let's check the fundamental score of Ardelyx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.513
Price to Book Ratio (EOD)Between0-17.358
Net Profit Margin (MRQ)Greater than0-0.555
Operating Margin (MRQ)Greater than0-0.600
Quick Ratio (MRQ)Greater than15.849
Current Ratio (MRQ)Greater than14.123
Debt to Asset Ratio (MRQ)Less than10.645
Debt to Equity Ratio (MRQ)Less than11.816
Return on Equity (MRQ)Greater than0.15-0.282
Return on Assets (MRQ)Greater than0.05-0.100
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Ardelyx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.171
Ma 20Greater thanMa 503.816
Ma 50Greater thanMa 1003.963
Ma 100Greater thanMa 2004.543
OpenGreater thanClose4.390
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Ardelyx Inc

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-18 23:38:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ardelyx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • A Net Profit Margin of -55.5% means that $-0.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ardelyx Inc:

  • The MRQ is -55.5%. The company is making a huge loss. -2
  • The TTM is -18.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-55.5%TTM-18.7%-36.8%
TTM-18.7%YOY-51.6%+32.9%
TTM-18.7%5Y-1,141.1%+1,122.4%
5Y-1,141.1%10Y-8,012.7%+6,871.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.5%-92.7%+37.2%
TTM-18.7%-140.3%+121.6%
YOY-51.6%-196.4%+144.8%
3Y-168.2%-248.5%+80.3%
5Y-1,141.1%-343.4%-797.7%
10Y-8,012.7%-496.2%-7,516.5%
4.3.1.2. Return on Assets

Shows how efficient Ardelyx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • -10.0% Return on Assets means that Ardelyx generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ardelyx Inc:

  • The MRQ is -10.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.0%TTM-3.5%-6.5%
TTM-3.5%YOY-5.8%+2.3%
TTM-3.5%5Y-11.2%+7.7%
5Y-11.2%10Y-11.6%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.0%-11.6%+1.6%
TTM-3.5%-11.6%+8.1%
YOY-5.8%-11.4%+5.6%
3Y-6.7%-11.8%+5.1%
5Y-11.2%-12.0%+0.8%
10Y-11.6%-13.7%+2.1%
4.3.1.3. Return on Equity

Shows how efficient Ardelyx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • -28.2% Return on Equity means Ardelyx generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ardelyx Inc:

  • The MRQ is -28.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.2%TTM-9.3%-18.9%
TTM-9.3%YOY-11.3%+2.0%
TTM-9.3%5Y-21.8%+12.5%
5Y-21.8%10Y-19.3%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.2%-13.6%-14.6%
TTM-9.3%-15.0%+5.7%
YOY-11.3%-14.5%+3.2%
3Y-14.8%-16.9%+2.1%
5Y-21.8%-17.5%-4.3%
10Y-19.3%-19.9%+0.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ardelyx Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ardelyx is operating .

  • Measures how much profit Ardelyx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • An Operating Margin of -60.0% means the company generated $-0.60  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ardelyx Inc:

  • The MRQ is -60.0%. The company is operating very inefficient. -2
  • The TTM is -15.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-60.0%TTM-15.5%-44.5%
TTM-15.5%YOY-43.8%+28.3%
TTM-15.5%5Y-1,101.1%+1,085.6%
5Y-1,101.1%10Y-7,680.8%+6,579.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.0%-229.2%+169.2%
TTM-15.5%-249.0%+233.5%
YOY-43.8%-208.5%+164.7%
3Y-157.7%-223.8%+66.1%
5Y-1,101.1%-346.1%-755.0%
10Y-7,680.8%-475.5%-7,205.3%
4.3.2.2. Operating Ratio

Measures how efficient Ardelyx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.46 means that the operating costs are $1.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ardelyx Inc:

  • The MRQ is 1.459. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.138. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.459TTM1.138+0.321
TTM1.138YOY1.488-0.350
TTM1.1385Y12.139-11.001
5Y12.13910Y97.440-85.301
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4592.110-0.651
TTM1.1382.684-1.546
YOY1.4883.096-1.608
3Y2.6073.652-1.045
5Y12.1394.745+7.394
10Y97.4406.614+90.826
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ardelyx Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ardelyx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.12 means the company has $4.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ardelyx Inc:

  • The MRQ is 4.123. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.236. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.123TTM4.236-0.113
TTM4.236YOY4.397-0.160
TTM4.2365Y4.194+0.042
5Y4.19410Y7.702-3.507
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1233.661+0.462
TTM4.2363.846+0.390
YOY4.3974.140+0.257
3Y3.6584.688-1.030
5Y4.1945.746-1.552
10Y7.7026.147+1.555
4.4.3.2. Quick Ratio

Measures if Ardelyx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • A Quick Ratio of 5.85 means the company can pay off $5.85 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ardelyx Inc:

  • The MRQ is 5.849. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.887. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.849TTM5.887-0.038
TTM5.887YOY6.476-0.589
TTM5.8875Y5.755+0.132
5Y5.75510Y9.995-4.239
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8492.826+3.023
TTM5.8873.182+2.705
YOY6.4763.786+2.690
3Y4.9334.311+0.622
5Y5.7555.703+0.052
10Y9.9956.454+3.541
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ardelyx Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ardelyx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ardelyx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.64 means that Ardelyx assets are financed with 64.5% credit (debt) and the remaining percentage (100% - 64.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ardelyx Inc:

  • The MRQ is 0.645. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.597. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.645TTM0.597+0.048
TTM0.597YOY0.439+0.158
TTM0.5975Y0.475+0.122
5Y0.47510Y0.342+0.133
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6450.329+0.316
TTM0.5970.349+0.248
YOY0.4390.331+0.108
3Y0.5150.340+0.175
5Y0.4750.349+0.126
10Y0.3420.379-0.037
4.5.4.2. Debt to Equity Ratio

Measures if Ardelyx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 181.6% means that company has $1.82 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ardelyx Inc:

  • The MRQ is 1.816. The company is just able to pay all its debts with equity.
  • The TTM is 1.498. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.816TTM1.498+0.318
TTM1.498YOY0.820+0.677
TTM1.4985Y0.973+0.525
5Y0.97310Y0.654+0.319
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8160.379+1.437
TTM1.4980.437+1.061
YOY0.8200.414+0.406
3Y1.1320.450+0.682
5Y0.9730.464+0.509
10Y0.6540.515+0.139
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ardelyx generates.

  • Above 15 is considered overpriced but always compare Ardelyx to the Biotechnology industry mean.
  • A PE ratio of -7.14 means the investor is paying $-7.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ardelyx Inc:

  • The EOD is -6.513. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.138. Based on the earnings, the company is expensive. -2
  • The TTM is -119.224. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.513MRQ-7.138+0.625
MRQ-7.138TTM-119.224+112.086
TTM-119.224YOY-1.093-118.131
TTM-119.2245Y-27.783-91.441
5Y-27.78310Y-19.578-8.205
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.513-2.304-4.209
MRQ-7.138-2.080-5.058
TTM-119.224-2.564-116.660
YOY-1.093-3.764+2.671
3Y-40.037-3.773-36.264
5Y-27.783-6.193-21.590
10Y-19.578-6.833-12.745
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ardelyx Inc:

  • The EOD is -6.910. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.573. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 283.870. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.910MRQ-7.573+0.663
MRQ-7.573TTM283.870-291.443
TTM283.870YOY-19.860+303.731
TTM283.8705Y48.526+235.345
5Y48.52610Y14.355+34.171
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.910-3.132-3.778
MRQ-7.573-2.705-4.868
TTM283.870-3.666+287.536
YOY-19.860-4.405-15.455
3Y88.143-5.059+93.202
5Y48.526-8.477+57.003
10Y14.355-9.304+23.659
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ardelyx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.06 means the investor is paying $8.06 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ardelyx Inc:

  • The EOD is 7.358. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.064. Based on the equity, the company is overpriced. -1
  • The TTM is 9.420. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.358MRQ8.064-0.706
MRQ8.064TTM9.420-1.356
TTM9.420YOY8.040+1.380
TTM9.4205Y8.228+1.192
5Y8.22810Y11.330-3.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.3581.953+5.405
MRQ8.0641.843+6.221
TTM9.4202.112+7.308
YOY8.0402.441+5.599
3Y7.7362.494+5.242
5Y8.2283.661+4.567
10Y11.3304.311+7.019
4.6.2. Total Gains per Share

2.4. Latest News of Ardelyx Inc

Does Ardelyx Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Ardelyx Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-07
14:01
Cantor Fitzgerald reiterates Overweight rating on Ardelyx stockRead
2025-07-04
19:38
High Growth Tech Stocks In The US To Watch This July 2025Read
2025-07-02
19:38
Ardelyx spike attributed to Xphozah legal updateRead
2025-07-01
19:38
High Growth Tech Stocks in US Market to WatchRead
2025-06-27
19:38
Exploring Three High Growth Tech Stocks In The US MarketRead
2025-06-26
19:38
Exploring High Growth Tech Stocks In The US MarketRead
2025-06-23
19:38
Exploring 3 High Growth Tech Stocks In The US MarketRead
2025-06-19
19:38
Exploring Three High Growth Tech Stocks In The US MarketRead
2025-06-17
13:38
Exploring High Growth Tech Opportunities in US MarketsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ardelyx Inc.

4.8.1. Institutions holding Ardelyx Inc

Institutions are holding 70.108% of the shares of Ardelyx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31HHG PLC10.43950.0674249770065890652.4154
2025-03-31BlackRock Inc7.50190.001917948653-572824-3.0928
2025-03-31Vanguard Group Inc6.26830.0013149972346345754.4182
2025-03-31Macquarie Group Ltd4.66370.0716111581398115477.8436
2025-03-31State Street Corp4.25340.002110176519-1416395-12.2178
2025-03-31Marshall Wace Asset Management Ltd3.50410.0523838380982689907201.761
2025-03-31Millennium Management LLC2.70220.016964652623501782118.1645
2025-03-31Geode Capital Management, LLC2.37090.002256726091628792.9562
2025-03-31Nuveen, LLC1.42460.0051340844534084450
2025-03-31Morgan Stanley - Brokerage Accounts1.34010.0011320633878464032.4004
2025-03-31Citadel Advisors Llc1.33350.003319035569973728.0949
2025-03-31Bank of America Corp1.22380.00122927908100425252.2054
2025-03-31Jane Street Group LLC1.02190.0032445048121728899.1471
2025-03-31Oracle Investment Management Inc1.0055.9563240443831500715.0762
2025-03-31Goldman Sachs Group Inc0.99420.0019237873822148610.267
2025-03-31Northern Trust Corp0.90820.00162172819218451.0156
2024-12-31Nuveen Asset Management, LLC0.90740.0031217099940380.1863
2025-03-31Two Seas Capital LP0.88620.328212033726500014.2831
2025-03-31Charles Schwab Investment Management Inc0.86420.00192067528323931.5917
2025-03-31Trexquant Investment LP0.73050.0998174773384142292.8403
Total 54.34366.6217130019917+20795172+16.0%

4.9.2. Funds holding Ardelyx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Macquarie Small Cap Core I3.87040.763592600341285791.4081
2025-04-30Vanguard Total Stock Mkt Idx Inv3.03430.002372598042141003.0387
2025-05-31iShares Russell 2000 ETF2.45970.0351588492600
2025-05-31SPDR® S&P Biotech ETF1.89220.35414527096267820.5951
2025-03-31Janus Henderson Global Life Sciences1.73420.43314149110-110070-2.5843
2025-03-31Janus Henderson Global Life Sciences D1.73420.43364149110-15340-0.3684
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.55290.0201371536947740.1287
2025-03-31Janus Global Life Science AUSD1.40320.43123357258-23512-0.6955
2025-04-30Janus Henderson Glb Life Scn I2 USD1.40010.49263349824-7434-0.2214
2025-03-31Janus Henderson Triton D1.02480.21672451882-25525-1.0303
2025-03-31Janus Henderson US SMID Cap Growth1.02480.2172451882-39027-1.5668
2025-03-31Fidelity Small Cap Index0.9840.04782354331140890.602
2025-05-31iShares Russell 2000 Growth ETF0.85180.0677203808500
2025-03-31Janus Henderson Hrzn Biotec E2 USD0.69741.650516686321411849.2431
2025-04-30Nuveen Quant Small Cap Equity R60.67050.28691604210-39900-2.4268
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.56960.0122136270000
2025-04-30Fidelity Extended Market Index0.55560.02031329266159521.2146
2025-04-30Vanguard Russell 2000 ETF0.48980.05461171964726896.6124
2025-05-31Schwab US Small-Cap ETF™0.4720.0251129228-3034-0.268
2025-04-30CREF Stock R30.46680.0052111690000
Total 26.88835.569564331611+354307+0.6%

5.3. Insider Transactions

Insiders are holding 2.223% of the shares of Ardelyx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-09David M MottBUY2000003.69
2025-05-20Elizabeth A GrammerSELL59924.08
2025-05-20Eric Duane FosterSELL25074.08
2025-05-20Justin A RenzSELL72184.08
2025-05-20Laura A WilliamsSELL64214.08
2025-05-20Michael RaabSELL468174.08
2025-05-20Mike KelliherSELL145224.08
2025-05-15David M MottBUY1000003.29
2025-05-02David M MottBUY3813774.22
2025-05-02Michael RaabSELL416664.25
2025-04-04Michael RaabSELL416664.59
2025-03-07Michael RaabSELL416685.36
2025-02-24David M MottBUY777295
2025-02-20Laura A WilliamsSELL49415.62
2025-02-20Michael RaabSELL229645.62
2025-02-20Justin A RenzSELL51715.62
2025-01-31Michael RaabSELL416665.36
2025-01-21David M MottBUY1990004.99
2025-01-07Michael RaabSELL416665.31
2024-12-19David M MottBUY2133004.67
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets410,194
Total Liabilities264,518
Total Stockholder Equity145,676
 As reported
Total Liabilities 264,518
Total Stockholder Equity+ 145,676
Total Assets = 410,194

Assets

Total Assets410,194
Total Current Assets312,692
Long-term Assets97,502
Total Current Assets
Cash And Cash Equivalents 30,808
Short-term Investments 183,144
Net Receivables 46,467
Inventory 23,776
Other Current Assets 28,497
Total Current Assets  (as reported)312,692
Total Current Assets  (calculated)312,692
+/-0
Long-term Assets
Property Plant Equipment 5,335
Long-term Assets Other 92,167
Long-term Assets  (as reported)97,502
Long-term Assets  (calculated)97,502
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities75,840
Long-term Liabilities188,678
Total Stockholder Equity145,676
Total Current Liabilities
Short-term Debt 1,302
Accounts payable 13,722
Other Current Liabilities 49,903
Total Current Liabilities  (as reported)75,840
Total Current Liabilities  (calculated)64,927
+/- 10,913
Long-term Liabilities
Long term Debt 151,301
Capital Lease Obligations 3,807
Long-term Liabilities  (as reported)188,678
Long-term Liabilities  (calculated)155,108
+/- 33,570
Total Stockholder Equity
Common Stock24
Retained Earnings -926,484
Accumulated Other Comprehensive Income 18
Other Stockholders Equity 1,072,118
Total Stockholder Equity (as reported)145,676
Total Stockholder Equity (calculated)145,676
+/-0
Other
Capital Stock24
Cash and Short Term Investments 213,952
Common Stock Shares Outstanding 238,624
Current Deferred Revenue10,913
Liabilities and Stockholders Equity 410,194
Net Debt 124,300
Net Invested Capital 296,977
Net Working Capital 236,852
Property Plant and Equipment Gross 5,335
Short Long Term Debt Total 155,108



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
37,884
0
0
0
42,904
40,548
123,478
117,729
113,414
105,399
148,188
138,066
116,946
180,498
155,379
241,317
213,131
187,765
164,122
143,105
157,903
142,837
228,536
206,668
183,332
166,135
137,980
119,410
259,782
235,322
217,343
198,555
201,562
210,293
204,982
170,848
149,913
129,408
131,610
144,672
190,066
217,019
211,203
289,379
297,579
342,382
343,488
367,863
435,754
410,194
410,194435,754367,863343,488342,382297,579289,379211,203217,019190,066144,672131,610129,408149,913170,848204,982210,293201,562198,555217,343235,322259,782119,410137,980166,135183,332206,668228,536142,837157,903143,105164,122187,765213,131241,317155,379180,498116,946138,066148,188105,399113,414117,729123,47840,54842,90400037,884
   > Total Current Assets 
0
0
0
0
41,836
39,115
122,147
116,373
111,283
101,906
143,923
133,471
112,235
175,697
150,404
234,200
203,992
178,008
153,945
133,630
149,871
135,320
221,688
199,322
177,721
154,312
127,241
110,834
252,376
228,582
211,626
193,793
195,238
205,376
186,492
153,379
134,799
114,225
114,107
119,875
154,484
167,047
162,118
241,216
246,111
257,939
263,020
284,098
356,452
312,692
312,692356,452284,098263,020257,939246,111241,216162,118167,047154,484119,875114,107114,225134,799153,379186,492205,376195,238193,793211,626228,582252,376110,834127,241154,312177,721199,322221,688135,320149,871133,630153,945178,008203,992234,200150,404175,697112,235133,471143,923101,906111,283116,373122,14739,11541,8360000
       Cash And Cash Equivalents 
32,903
0
0
0
34,435
33,221
117,814
112,044
107,286
98,318
141,534
129,047
107,004
171,678
146,669
160,360
74,598
71,213
63,636
59,454
75,383
67,745
91,751
75,015
78,768
92,036
89,626
92,673
181,133
105,895
100,494
91,009
91,032
84,070
86,745
75,288
72,428
47,077
53,408
61,628
96,140
92,487
30,058
33,767
21,470
36,147
41,890
47,429
64,932
30,808
30,80864,93247,42941,89036,14721,47033,76730,05892,48796,14061,62853,40847,07772,42875,28886,74584,07091,03291,009100,494105,895181,13392,67389,62692,03678,76875,01591,75167,74575,38359,45463,63671,21374,598160,360146,669171,678107,004129,047141,53498,318107,286112,044117,81433,22134,43500032,903
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,726
126,225
102,210
85,088
69,834
58,593
59,704
120,980
111,391
89,321
59,524
34,315
10,870
66,379
117,312
104,347
94,488
95,452
94,142
85,064
66,363
44,261
42,627
27,604
28,995
27,769
37,886
97,521
131,313
162,829
166,431
144,071
142,973
185,168
183,144
183,144185,168142,973144,071166,431162,829131,31397,52137,88627,76928,99527,60442,62744,26166,36385,06494,14295,45294,488104,347117,31266,37910,87034,31559,52489,321111,391120,98059,70458,59369,83485,088102,210126,22569,726000000000000000
       Net Receivables 
0
0
0
0
6,436
4,977
3,025
2,660
2,584
2,043
27
0
0
0
0
0
0
0
0
0
10,796
5,000
5,030
5,167
5,085
7
17
2,699
750
750
750
750
0
5,783
0
287
502
4,394
5,623
5,208
7,733
12,120
9,109
43,263
22,031
28,162
37,241
53,195
57,705
46,467
46,46757,70553,19537,24128,16222,03143,2639,10912,1207,7335,2085,6234,39450228705,78307507507507502,6991775,0855,1675,0305,00010,796000000000272,0432,5842,6603,0254,9776,4360000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,487
4,529
1,250
3,282
4,823
7,617
8,524
12,448
9,813
13,756
11,378
21,173
23,776
23,77621,17311,37813,7569,81312,4488,5247,6174,8233,2821,2504,5293,4870000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
1,068
1,433
1,331
1,356
2,131
3,493
4,265
4,595
4,711
4,801
4,975
7,117
9,139
9,757
10,177
9,475
8,032
7,517
6,848
7,346
5,611
11,823
10,739
8,576
7,406
6,740
5,717
4,762
6,324
4,917
18,490
17,469
15,114
15,183
17,503
24,797
35,582
49,972
49,085
48,163
51,468
84,443
80,468
83,765
79,302
97,502
97,50279,30283,76580,46884,44351,46848,16349,08549,97235,58224,79717,50315,18315,11417,46918,4904,9176,3244,7625,7176,7407,4068,57610,73911,8235,6117,3466,8487,5178,0329,47510,1779,7579,1397,1174,9754,8014,7114,5954,2653,4932,1311,3561,3311,4331,0680000
       Property Plant Equipment 
844
0
0
0
530
551
1,138
1,152
2,131
3,289
4,061
4,391
4,711
4,597
4,827
6,969
8,991
8,915
9,335
8,622
8,032
7,358
6,689
5,996
5,611
10,473
9,388
8,396
7,406
6,436
5,446
4,513
4,210
3,959
17,185
16,231
15,114
13,955
12,595
11,476
10,518
9,074
8,117
7,639
6,598
5,660
5,340
4,653
3,875
5,335
5,3353,8754,6535,3405,6606,5987,6398,1179,07410,51811,47612,59513,95515,11416,23117,1853,9594,2104,5135,4466,4367,4068,3969,38810,4735,6115,9966,6897,3588,0328,6229,3358,9158,9916,9694,8274,5974,7114,3914,0613,2892,1311,1521,138551530000844
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,11400000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
538
882
193
204
204
204
204
204
204
204
148
148
148
842
842
853
159
159
159
1,350
1,350
1,350
1,351
180
314
304
271
249
552
958
1,305
1,238
1,150
1,228
4,908
13,321
25,064
40,898
40,968
40,524
44,870
78,783
75,128
79,112
75,427
92,167
92,16775,42779,11275,12878,78344,87040,52440,96840,89825,06413,3214,9081,2281,1501,2381,3059585522492713043141801,3511,3501,3501,3501591591598538428421481481482042042042042042042041938825380000
> Total Liabilities 
39,121
0
0
0
50,228
41,792
60,611
54,428
52,732
47,399
5,928
12,936
8,045
12,750
14,774
18,424
19,980
20,081
19,144
16,468
18,591
13,861
65,122
65,220
67,519
74,294
69,363
70,252
73,127
67,565
70,993
67,215
75,450
79,482
87,413
89,416
67,296
65,218
78,568
77,811
91,737
91,598
88,042
98,218
130,763
191,491
196,498
209,566
262,465
264,518
264,518262,465209,566196,498191,491130,76398,21888,04291,59891,73777,81178,56865,21867,29689,41687,41379,48275,45067,21570,99367,56573,12770,25269,36374,29467,51965,22065,12213,86118,59116,46819,14420,08119,98018,42414,77412,7508,04512,9365,92847,39952,73254,42860,61141,79250,22800039,121
   > Total Current Liabilities 
16,791
0
0
0
17,139
18,768
27,334
19,397
5,557
19,912
5,546
12,584
7,723
12,458
14,061
17,635
19,201
19,314
18,388
15,727
17,871
13,162
15,609
15,549
17,728
20,826
16,333
17,679
22,220
23,417
33,650
16,534
28,416
41,790
57,785
68,768
57,548
47,843
48,699
51,951
74,628
63,063
61,689
43,529
50,393
56,895
62,436
70,499
77,830
75,840
75,84077,83070,49962,43656,89550,39343,52961,68963,06374,62851,95148,69947,84357,54868,76857,78541,79028,41616,53433,65023,41722,22017,67916,33320,82617,72815,54915,60913,16217,87115,72718,38819,31419,20117,63514,06112,4587,72312,5845,54619,9125,55719,39727,33418,76817,13900016,791
       Short-term Debt 
0
0
0
0
0
0
0
0
15,979
0
0
0
0
0
0
0
0
0
0
0
0
0
10,891
11,678
585
4,204
4,636
5,008
6,399
12,867
19,368
5,540
8,401
19,491
42,479
51,226
39,248
33,323
33,755
34,123
34,499
34,876
35,262
8,642
4,435
4,314
7,100
5,134
1,562
1,302
1,3021,5625,1347,1004,3144,4358,64235,26234,87634,49934,12333,75533,32339,24851,22642,47919,4918,4015,54019,36812,8676,3995,0084,6364,20458511,67810,891000000000000015,97900000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,836
0
0
2,102
0
0
1,183
7,437
13,716
0
4,167
16,667
36,111
44,444
32,264
26,139
26,373
26,541
26,711
26,880
27,052
0
0
0
0
0
0
0
000000027,05226,88026,71126,54126,37326,13932,26444,44436,11116,6674,167013,7167,4371,183002,1020048,8360000000000000000000000
       Accounts payable 
1,146
0
0
0
2,284
2,530
2,308
1,022
3,129
2,544
2,684
2,714
2,777
4,875
4,746
6,298
5,635
5,893
4,713
1,723
3,933
1,761
3,172
2,269
16,728
2,925
1,260
2,689
2,187
1,012
4,212
2,490
5,626
5,378
2,587
4,263
4,277
5,030
4,294
3,113
10,859
10,513
5,294
7,736
11,138
17,277
10,881
15,824
16,000
13,722
13,72216,00015,82410,88117,27711,1387,7365,29410,51310,8593,1134,2945,0304,2774,2632,5875,3785,6262,4904,2121,0122,1872,6891,2602,92516,7282,2693,1721,7613,9331,7234,7135,8935,6356,2984,7464,8752,7772,7142,6842,5443,1291,0222,3082,5302,2840001,146
       Other Current Liabilities 
15,645
0
0
0
14,855
16,238
1,805
1,895
2,428
1,415
2,862
9,870
4,946
7,583
9,315
11,337
13,566
13,421
13,675
14,004
13,938
10,401
546
602
585
13,697
10,437
9,982
9,093
6,172
7,829
7,619
10,212
14,198
11,307
12,752
9,296
9,490
10,650
10,712
16,034
12,129
15,174
23,079
27,638
28,718
33,626
42,269
51,144
49,903
49,90351,14442,26933,62628,71827,63823,07915,17412,12916,03410,71210,6509,4909,29612,75211,30714,19810,2127,6197,8296,1729,0939,98210,43713,69758560254610,40113,93814,00413,67513,42113,56611,3379,3157,5834,9469,8702,8621,4152,4281,8951,80516,23814,85500015,645
   > Long-term Liabilities 
0
0
0
0
33,089
23,024
33,277
35,031
47,175
27,487
382
352
322
292
713
789
779
767
756
741
720
699
49,513
49,671
49,791
53,468
53,030
52,573
50,907
44,148
37,343
50,681
47,034
37,692
29,628
20,648
9,748
17,375
29,869
25,860
17,109
28,535
26,353
54,689
80,370
134,596
134,062
139,067
184,635
188,678
188,678184,635139,067134,062134,59680,37054,68926,35328,53517,10925,86029,86917,3759,74820,64829,62837,69247,03450,68137,34344,14850,90752,57353,03053,46849,79149,67149,51369972074175676777978971329232235238227,48747,17535,03133,27723,02433,0890000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,836
49,020
49,209
49,399
49,597
49,803
48,831
42,793
36,735
50,681
46,621
34,348
15,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000015,13334,34846,62150,68136,73542,79348,83149,80349,59749,39949,20949,02048,8360000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-15,979
0
0
0
0
0
0
0
0
0
0
0
0
0
-10,891
-11,678
-585
1,967
1,115
266
-1,715
-8,797
-15,934
-2,770
-5,871
-17,682
-27,747
-37,166
-26,008
-20,919
-22,207
-23,454
-24,750
-26,064
-27,405
-1,434
1,725
778
-2,454
-1,349
1,023
2,505
2,5051,023-1,349-2,4547781,725-1,434-27,405-26,064-24,750-23,454-22,207-20,919-26,008-37,166-27,747-17,682-5,871-2,770-15,934-8,797-1,7152661,1151,967-585-11,678-10,8910000000000000-15,97900000000
       Long-term Liabilities Other 
0
0
0
0
0
0
107
72
122
297
382
352
322
292
713
789
779
767
756
741
0
699
677
651
0
4,069
3,433
2,770
2,076
1,355
608
0
413
3,344
14,495
0
14,475
17,375
0
25,860
17,109
28,535
26,353
170
0
0
0
0
0
0
00000017026,35328,53517,10925,860017,37514,475014,4953,34441306081,3552,0762,7703,4334,0690651677699074175676777978971329232235238229712272107000000
       Deferred Long Term Liability 
0
0
0
0
0
0
33,170
34,959
31,074
27,190
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000027,19031,07434,95933,170000000
> Total Stockholder Equity
0
0
0
0
-7,324
-1,244
62,867
63,301
60,682
58,000
142,260
125,130
108,901
167,748
140,605
222,893
193,151
167,684
144,978
126,637
139,312
128,976
163,414
141,448
115,813
91,841
68,617
49,158
186,655
167,757
146,350
131,340
126,112
130,811
117,569
81,432
82,617
64,190
53,042
66,861
98,329
125,421
123,161
191,161
166,816
150,891
146,990
158,297
173,289
145,676
145,676173,289158,297146,990150,891166,816191,161123,161125,42198,32966,86153,04264,19082,61781,432117,569130,811126,112131,340146,350167,757186,65549,15868,61791,841115,813141,448163,414128,976139,312126,637144,978167,684193,151222,893140,605167,748108,901125,130142,26058,00060,68263,30162,867-1,244-7,3240000
   Common Stock
0
0
0
0
0
1
2
2
2
3
3
3
3
4
4
5
5
5
5
5
5
5
6
6
6
6
6
6
9
9
9
9
9
10
10
11
13
14
15
19
20
21
22
23
23
23
23
24
24
24
2424242323232322212019151413111010999996666665555555443333222100000
   Retained Earnings Total Equity0000000-824,031-806,910-780,137-790,832-767,939-741,001-712,9300-633,109-587,920-554,765-525,889-507,781-482,825-460,452-440,662-417,123-391,656-365,512-337,650-313,524-291,232-278,214-288,328-267,604-241,883-213,875-182,601-153,570-124,955-101,488-84,488-66,362-75,369-71,867-67,896-67,971000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-3,332
0
-123,478
-117,729
-3,634
-3,634
0
0
-3,808
-3,808
0
-25
-71
-48
-40
-10
-47
-91
-36
-17
-38
12
16
4
20
-44
317
90
-4
-7
4
3
-6
-88
-109
-114
-54
-20
-210
-201
224
-20
-101
185
57
18
1857185-101-20224-201-210-20-54-114-109-88-634-7-490317-442041612-38-17-36-91-47-10-40-48-71-250-3,808-3,80800-3,634-3,634-117,729-123,4780-3,3320000
   Capital Surplus 
0
0
0
0
0
0
130,836
131,195
132,547
133,366
208,619
209,615
210,386
292,699
294,171
405,514
407,092
409,610
412,617
414,970
417,568
420,294
476,968
479,109
481,357
483,479
485,718
489,810
647,078
650,617
653,805
657,130
680,872
718,728
750,664
0
795,540
805,265
821,075
857,788
878,500
932,330
947,380
0
0
0
0
0
0
0
0000000947,380932,330878,500857,788821,075805,265795,5400750,664718,728680,872657,130653,805650,617647,078489,810485,718483,479481,357479,109476,968420,294417,568414,970412,617409,610407,092405,514294,171292,699210,386209,615208,619133,366132,547131,195130,836000000
   Treasury Stock00000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
14,962
70,479
7,358
13,466
136,181
133,366
208,619
209,615
210,386
292,699
294,171
405,514
407,092
409,610
412,617
414,970
417,568
420,294
476,968
479,109
481,357
483,479
485,718
489,810
647,078
650,617
653,805
657,130
680,872
718,728
750,664
758,114
795,540
805,265
821,075
857,788
878,500
932,330
947,380
1,008,741
1,012,773
1,023,610
1,036,244
1,048,073
1,058,548
1,072,118
1,072,1181,058,5481,048,0731,036,2441,023,6101,012,7731,008,741947,380932,330878,500857,788821,075805,265795,540758,114750,664718,728680,872657,130653,805650,617647,078489,810485,718483,479481,357479,109476,968420,294417,568414,970412,617409,610407,092405,514294,171292,699210,386209,615208,619133,366136,18113,4667,35870,47914,9620000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue333,615
Cost of Revenue-50,556
Gross Profit283,059283,059
 
Operating Income (+$)
Gross Profit283,059
Operating Expense-311,009
Operating Income-27,950-27,950
 
Operating Expense (+$)
Research Development52,317
Selling General Administrative258,692
Selling And Marketing Expenses0
Operating Expense311,009311,009
 
Net Interest Income (+$)
Interest Income0
Interest Expense-20,094
Other Finance Cost-0
Net Interest Income-20,094
 
Pretax Income (+$)
Operating Income-27,950
Net Interest Income-20,094
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-38,870-17,030
EBIT - interestExpense = -38,870
-38,870
-19,042
Interest Expense20,094
Earnings Before Interest and Taxes (EBIT)-18,776-18,776
Earnings Before Interest and Taxes (EBITDA)-16,713
 
After tax Income (+$)
Income Before Tax-38,870
Tax Provision-266
Net Income From Continuing Ops-39,136-39,136
Net Income-39,136
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses354,714
Total Other Income/Expenses Net-10,92020,094
 

Technical Analysis of Ardelyx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ardelyx. The general trend of Ardelyx is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ardelyx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ardelyx Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ardelyx Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.645 < 5.73 < 6.53.

The bearish price targets are: 4.2699 > 3.88 > 3.49.

Know someone who trades $ARDX? Share this with them.👇

Ardelyx Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ardelyx Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ardelyx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ardelyx Inc. The current macd is 0.10203067.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ardelyx price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ardelyx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ardelyx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ardelyx Inc Daily Moving Average Convergence/Divergence (MACD) ChartArdelyx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ardelyx Inc. The current adx is 25.33.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ardelyx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Ardelyx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ardelyx Inc. The current sar is 3.65288486.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ardelyx Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ardelyx Inc. The current rsi is 70.17. The current phase is Overbought in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bear market: Short-term excessive buying, potential for relief decline. Consider shorting, be cautious of potential pullback. -1
  • Trending up: The RSI is trending up. +1
Ardelyx Inc Daily Relative Strength Index (RSI) ChartArdelyx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ardelyx Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ardelyx price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Ardelyx Inc Daily Stochastic Oscillator ChartArdelyx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ardelyx Inc. The current cci is 203.56.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Ardelyx Inc Daily Commodity Channel Index (CCI) ChartArdelyx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ardelyx Inc. The current cmo is 63.64.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ardelyx Inc Daily Chande Momentum Oscillator (CMO) ChartArdelyx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ardelyx Inc. The current willr is -4.80769231.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Ardelyx Inc Daily Williams %R ChartArdelyx Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ardelyx Inc.

Ardelyx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ardelyx Inc. The current atr is 0.21148038.

Ardelyx Inc Daily Average True Range (ATR) ChartArdelyx Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ardelyx Inc. The current obv is 106,314,024.

Ardelyx Inc Daily On-Balance Volume (OBV) ChartArdelyx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ardelyx Inc. The current mfi is 81.01.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Ardelyx Inc Daily Money Flow Index (MFI) ChartArdelyx Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ardelyx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Ardelyx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ardelyx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.171
Ma 20Greater thanMa 503.816
Ma 50Greater thanMa 1003.963
Ma 100Greater thanMa 2004.543
OpenGreater thanClose4.390
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ardelyx with someone you think should read this too:
  • Are you bullish or bearish on Ardelyx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ardelyx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ardelyx Inc

I send you an email if I find something interesting about Ardelyx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ardelyx Inc.

Receive notifications about Ardelyx Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.